PHREESIA INC (PHR) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:PHR - US71944F1066 - Common Stock
20.49 USD
-0.04 (-0.19%)
20.49 USD
0 (0%)
Overall PHR gets a fundamental rating of 4 out of 10. We evaluated PHR against 35 industry peers in the Health Care Technology industry. No worries on liquidiy or solvency for PHR as it has an excellent financial health rating, but there are worries on the profitability. PHR is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
PHR had negative earnings in the past year.
PHR had a positive operating cash flow in the past year.
PHR had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: PHR reported negative operating cash flow in multiple years.
1.2 Ratios
PHR's Return On Assets of -5.89% is fine compared to the rest of the industry. PHR outperforms 68.57% of its industry peers.
PHR has a better Return On Equity (-8.07%) than 68.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.89% | ||
| ROE | -8.07% | ||
| ROIC | N/A |
ROA(3y)-33.2%
ROA(5y)-26.37%
ROE(3y)-45.91%
ROE(5y)-35.28%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a decent Gross Margin value of 68.02%, PHR is doing good in the industry, outperforming 71.43% of the companies in the same industry.
PHR's Gross Margin has been stable in the last couple of years.
PHR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 68.02% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.16%
GM growth 5Y1.12%
2. Health
2.1 Basic Checks
PHR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PHR has been increased compared to 1 year ago.
The number of shares outstanding for PHR has been increased compared to 5 years ago.
Compared to 1 year ago, PHR has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 5.15 indicates that PHR is not in any danger for bankruptcy at the moment.
The Altman-Z score of PHR (5.15) is better than 82.86% of its industry peers.
PHR has a debt to FCF ratio of 0.42. This is a very positive value and a sign of high solvency as it would only need 0.42 years to pay back of all of its debts.
PHR's Debt to FCF ratio of 0.42 is amongst the best of the industry. PHR outperforms 82.86% of its industry peers.
A Debt/Equity ratio of 0.02 indicates that PHR is not too dependend on debt financing.
PHR has a better Debt to Equity ratio (0.02) than 68.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.42 | ||
| Altman-Z | 5.15 |
ROIC/WACCN/A
WACC10.22%
2.3 Liquidity
A Current Ratio of 2.12 indicates that PHR has no problem at all paying its short term obligations.
The Current ratio of PHR (2.12) is comparable to the rest of the industry.
PHR has a Quick Ratio of 2.12. This indicates that PHR is financially healthy and has no problem in meeting its short term obligations.
With a Quick ratio value of 2.12, PHR perfoms like the industry average, outperforming 48.57% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.12 | ||
| Quick Ratio | 2.12 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 62.50% over the past year.
The Revenue has grown by 15.31% in the past year. This is quite good.
PHR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 27.46% yearly.
EPS 1Y (TTM)62.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%103.23%
Revenue 1Y (TTM)15.31%
Revenue growth 3Y25.34%
Revenue growth 5Y27.46%
Sales Q2Q%14.83%
3.2 Future
Based on estimates for the next years, PHR will show a very strong growth in Earnings Per Share. The EPS will grow by 53.29% on average per year.
Based on estimates for the next years, PHR will show a quite strong growth in Revenue. The Revenue will grow by 11.66% on average per year.
EPS Next Y96.66%
EPS Next 2Y50.93%
EPS Next 3Y53.29%
EPS Next 5YN/A
Revenue Next Year13.85%
Revenue Next 2Y12.76%
Revenue Next 3Y12.36%
Revenue Next 5Y11.66%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
PHR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
PHR is valuated quite expensively with a Price/Forward Earnings ratio of 72.22.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PHR is on the same level as its industry peers.
PHR's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 36.12.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 72.22 |
4.2 Price Multiples
PHR's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PHR is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 44.01 | ||
| EV/EBITDA | 586.94 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as PHR's earnings are expected to grow with 53.29% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y50.93%
EPS Next 3Y53.29%
5. Dividend
5.1 Amount
No dividends for PHR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
20.49
-0.04 (-0.19%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners99.81%
Inst Owner Change3.07%
Ins Owners4.56%
Ins Owner Change-1.76%
Market Cap1.23B
Revenue(TTM)449.67M
Net Income(TTM)-24.05M
Analysts85
Price Target34.48 (68.28%)
Short Float %6.25%
Short Ratio4.97
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)78.63%
Min EPS beat(2)41.66%
Max EPS beat(2)115.6%
EPS beat(4)4
Avg EPS beat(4)51.25%
Min EPS beat(4)8.94%
Max EPS beat(4)115.6%
EPS beat(8)8
Avg EPS beat(8)37.38%
EPS beat(12)12
Avg EPS beat(12)31.19%
EPS beat(16)15
Avg EPS beat(16)26.09%
Revenue beat(2)0
Avg Revenue beat(2)-0.27%
Min Revenue beat(2)-0.37%
Max Revenue beat(2)-0.18%
Revenue beat(4)0
Avg Revenue beat(4)-0.35%
Min Revenue beat(4)-0.56%
Max Revenue beat(4)-0.18%
Revenue beat(8)2
Avg Revenue beat(8)-0.13%
Revenue beat(12)5
Avg Revenue beat(12)0.4%
Revenue beat(16)9
Avg Revenue beat(16)1.43%
PT rev (1m)-1%
PT rev (3m)4.87%
EPS NQ rev (1m)-78%
EPS NQ rev (3m)90.36%
EPS NY rev (1m)5.09%
EPS NY rev (3m)76.92%
Revenue NQ rev (1m)-0.2%
Revenue NQ rev (3m)-0.89%
Revenue NY rev (1m)-0.18%
Revenue NY rev (3m)0.03%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 72.22 | ||
| P/S | 2.73 | ||
| P/FCF | 44.01 | ||
| P/OCF | 23.73 | ||
| P/B | 4.12 | ||
| P/tB | 8.65 | ||
| EV/EBITDA | 586.94 |
EPS(TTM)-0.42
EYN/A
EPS(NY)0.28
Fwd EY1.38%
FCF(TTM)0.47
FCFY2.27%
OCF(TTM)0.86
OCFY4.21%
SpS7.51
BVpS4.97
TBVpS2.37
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.89% | ||
| ROE | -8.07% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 68.02% | ||
| FCFM | 6.2% |
ROA(3y)-33.2%
ROA(5y)-26.37%
ROE(3y)-45.91%
ROE(5y)-35.28%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.16%
GM growth 5Y1.12%
F-Score7
Asset Turnover1.1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.42 | ||
| Debt/EBITDA | 2.35 | ||
| Cap/Depr | 84.53% | ||
| Cap/Sales | 5.3% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 2655.34% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.12 | ||
| Quick Ratio | 2.12 | ||
| Altman-Z | 5.15 |
F-Score7
WACC10.22%
ROIC/WACCN/A
Cap/Depr(3y)91.68%
Cap/Depr(5y)107.3%
Cap/Sales(3y)7.37%
Cap/Sales(5y)9.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)62.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%103.23%
EPS Next Y96.66%
EPS Next 2Y50.93%
EPS Next 3Y53.29%
EPS Next 5YN/A
Revenue 1Y (TTM)15.31%
Revenue growth 3Y25.34%
Revenue growth 5Y27.46%
Sales Q2Q%14.83%
Revenue Next Year13.85%
Revenue Next 2Y12.76%
Revenue Next 3Y12.36%
Revenue Next 5Y11.66%
EBIT growth 1Y73.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year249.5%
EBIT Next 3Y62.99%
EBIT Next 5Y37.25%
FCF growth 1Y132.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y186.75%
OCF growth 3YN/A
OCF growth 5Y108.09%
PHREESIA INC / PHR FAQ
Can you provide the ChartMill fundamental rating for PHREESIA INC?
ChartMill assigns a fundamental rating of 4 / 10 to PHR.
What is the valuation status for PHR stock?
ChartMill assigns a valuation rating of 3 / 10 to PHREESIA INC (PHR). This can be considered as Overvalued.
Can you provide the profitability details for PHREESIA INC?
PHREESIA INC (PHR) has a profitability rating of 2 / 10.
Is the dividend of PHREESIA INC sustainable?
The dividend rating of PHREESIA INC (PHR) is 0 / 10 and the dividend payout ratio is 0%.